Press Release

Endocrine Society welcomes European Commission's chemical strategy

Washington, DC October 14, 2020

Framework offers opportunity to protect public health from endocrine-disrupting chemicals

The Endocrine Society welcomed the European Commission’s new Chemical Strategy for Sustainability and its measures to protect the public from endocrine-disrupting chemicals. The communication was released Wednesday as part of the European Green Deal.

The strategy is designed to be the foundation for the biggest update to Europe’s chemical regulations in more than a decade. The chemical strategy commits to a hazard identification for endocrine-disrupting chemicals (EDCs), including strict measures to prevent them from being used in consumer products. In addition, the strategy calls for stricter data requirements for EDCs across all relevant legislation and to accelerate the development and adoption of better test methods.

“EDCs are linked to serious health problems, such as infertility, diabetes, obesity, cancer and issues with brain development,” said Barbara Demeneix, B.Sc., Ph.D., D.Sc., chair of the Society’s Endocrine-disrupting Chemicals Advisory Group. “We are pleased to see the European Commission has taken this significant first step towards further protecting the public from EDC exposure with its new chemical strategy. We now need further details and concrete actions to protect public health and minimize consumers' exposure to these hazardous chemicals.” 

The Commission also committed to introducing provisions for evaluating unintentional mixtures and will assess how best to address combination effects in the future.

In addition, the chemical strategy prioritizes control measures for poly- and perfluoroalkyl substances (PFAS) and address them with a group approach. These manmade endocrine-disrupting chemicals have leached into waterways and foods, and they can persist in the environment as well as our bodies. PFAS exposure is linked to health problems such as high cholesterol, disrupted thyroid function and altered immune response.

The Society has dedicated years to pressing for science-based policies to regulate EDCs, which mimic, block or otherwise interfere with the body’s hormones. We are pleased the European Commission has announced its intention of adopting a hazard-based approach to regulating these harmful chemicals. However, the practical features and implementation steps will be important, and the Society urges the Commission to clarify these details to permit concrete actions without further delay. 

EDCs are commonly found throughout our environment in consumer products, food containers, personal care products, pesticides and furniture. EDCs contribute to serious health problems such as diabetes, obesity, neurodevelopmental disorders and reproductive problems. Children, unborn children and adolescents’ developing bodies are particularly vulnerable to exposures. 

A series of economic analyses found EDC exposures may be costing the EU upwards of €157 billion ($177 billion) a year. Society experts led the effort to quantify the public health impact of EDCs on the economy. 

The Endocrine Society will continue to monitor progress on legislative proposals to ensure that they are effective in minimizing exposure to EDCs.  

###

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.


All Press Releases

Media Contacts

Colleen Williams Manager, Public Relations Phone: (202)-971-3611 [email protected]

Jenni Glenn Gingery Associate Director, Communications and Media Relations Phone: (202)-971-3655 [email protected]

All News & Advocacy

Hill Event
Patient Resources

The Hormone Health Network

Hormone Health Network
From bench to bedside and all the stages in between, the Hormone Health Network is committed to supporting patient and public education.

From bench to bedside and all the stages in between, the Hormone Health Network is committed to supporting patient and public education.

Podcast

Endocrine News Podcast

EndocrineNewsPodcast
The Endocrine News podcast brings you the latest research and clinical advances from experts in the field, whether you are in your car, office, or out for a run.

The Endocrine News podcast brings you the latest research and clinical advances from experts in the field, whether you are in your car, office, or out for a run.

Bench to Bedside

Endocrine Society Journals

Research
Our top-ranked peer-reviewed journals are among the first to publish major developments and discovery milestones.

Our top-ranked peer-reviewed journals are among the first to publish major developments and discovery milestones.

Back to top
Short on time?

We'll come to you...

Get updates on the latest breakthroughs, clinical practice guidelines, and career development opportunities, straight to your inbox

Then take the next step: Set up your free website account and get exclusive access to even more great tools & content!